These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


561 related items for PubMed ID: 9377576

  • 1. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 4. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr 01; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
    Dreyling MH, Roulston D, Bohlander SK, Vardiman J, Olopade OI.
    Genes Chromosomes Cancer; 1998 May 01; 22(1):72-8. PubMed ID: 9591637
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Visualization of mono-allelic chromosomal aberrations 3' and 5' of the cyclin D1 gene in mantle cell lymphoma using DNA fiber fluorescence in situ hybridization.
    de Boer CJ, Vaandrager JW, van Krieken JH, Holmes Z, Kluin PM, Schuuring E.
    Oncogene; 1997 Sep 25; 15(13):1599-603. PubMed ID: 9380412
    [Abstract] [Full Text] [Related]

  • 9. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN.
    J Neuropathol Exp Neurol; 1996 Oct 25; 55(10):1026-31. PubMed ID: 8857999
    [Abstract] [Full Text] [Related]

  • 10. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S, Mihara M, Nakahara Y, Kiyota A, Yoshihama Y, Ueyama Y, Matsumura T.
    Anticancer Res; 2000 Oct 25; 20(3B):2169-75. PubMed ID: 10928172
    [Abstract] [Full Text] [Related]

  • 11. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G, Scheubner M, Zimmermann Y, Kalla J, Katzenberger T, Hübler K, Roth S, Hiddemann W, Ott G, Dreyling M.
    Genes Chromosomes Cancer; 2006 Feb 25; 45(2):203-10. PubMed ID: 16258956
    [Abstract] [Full Text] [Related]

  • 12. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE, Gorgoulis V, Mariatos G, Zacharatos P, Kotsinas A, Garinis G, Trigidou R, Karameris A, Tsimara-Papastamatiou H, Kouloukousa M, Manolis EN, Kittas C.
    Anticancer Res; 1999 Feb 25; 19(3A):1893-9. PubMed ID: 10470133
    [Abstract] [Full Text] [Related]

  • 13. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
    de Boer CJ, van Krieken JH, Kluin-Nelemans HC, Kluin PM, Schuuring E.
    Oncogene; 1995 May 04; 10(9):1833-40. PubMed ID: 7753558
    [Abstract] [Full Text] [Related]

  • 14. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V, Hartmann E, Ott G, Campo E, Rosenwald A.
    J Clin Oncol; 2005 Sep 10; 23(26):6364-9. PubMed ID: 16155021
    [Abstract] [Full Text] [Related]

  • 15. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
    Ott MM, Helbing A, Ott G, Bartek J, Fischer L, Dürr A, Kreipe H, Müller-Hermelink HK.
    J Pathol; 1996 Jul 10; 179(3):238-42. PubMed ID: 8774476
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J, Kratzke RA, Niehans GA, Lincoln CE.
    Cancer Res; 1995 Dec 15; 55(24):6006-11. PubMed ID: 8521382
    [Abstract] [Full Text] [Related]

  • 17. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
    Tucker CA, Bebb G, Klasa RJ, Chhanabhai M, Lestou V, Horsman DE, Gascoyne RD, Wiestner A, Masin D, Bally M, Williams ME.
    Leuk Res; 2006 Apr 15; 30(4):449-57. PubMed ID: 16183118
    [Abstract] [Full Text] [Related]

  • 18. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M, Belaud-Rotureau MA, Fitoussi O, Carerre N, Bouabdallah K, Marit G, Dubus P, de Mascarel A, Merlio JP.
    Histopathology; 2006 Mar 15; 48(4):353-62. PubMed ID: 16487357
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
    Kaune KM, Neumann C, Hallermann C, Haller F, Schön MP, Middel P.
    Exp Dermatol; 2011 Apr 15; 20(4):331-5. PubMed ID: 21410763
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.
    Laryngoscope; 2002 Mar 15; 112(3):472-81. PubMed ID: 12148857
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.